Peri-operative treatment of anaemia in major orthopaedic surgery: A practical approach from Spain

Blood Transfusion

Volumn 15, Issue 4, 2017, Pages 296-306

  Bisbe, Elvira ^a   Basora, Misericordia ^b   Colomina, María J ^c  

^a HOSPITAL DE L ESPERANÇA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Anaemia; Intravenous iron; Iron deficiency; Orthopaedic surgery; Recombinant erythropoietin

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

ALGORITHM; ANEMIA; BIOCHEMICAL ANALYSIS; BLOOD CELL COUNT; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFICACY; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; HEALTH CARE SYSTEM; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DEPARTMENT; HUMAN; LABORATORY TEST; MANAGED CARE; ORTHOPEDIC SURGERY; PATIENT RISK; PERSONAL EXPERIENCE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SPAIN; SURGICAL APPROACH; BLOOD TRANSFUSION; FEMALE; MALE; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; PROCEDURES;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE;

EID: 85021824557     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0177-16     Document Type: Review

References (65)

1. Gombotz H RP, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 150-6.
2. Gombotz H, Rehak PH, Shander A, Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54: 2646-57.
3. Bosch MA, Contreras E, Madoz P, et al. The epidemiology of blood component transfusion in Catalonia, Northeastern Spain. Transfusion 2011; 51: 105-16.
4. Walsh TS, Palmer J, Watson D, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2012; 108: 63-71.
5. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-92.
6. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-8.
7. Spahn DR, Moch H, Hofmann A, Isbister JP. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008; 109: 951-3.
8. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
9. Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52.
10. th Session of the Executive Committee CE146/INF/7. Resolution WHA63.12. Available at: http://apps.who.int/iris/bitstream/10665/169232/1/CE146-INF-7-e. pdf. Accessed on 21/05/2010.
11. Llau J V, Bisbe E. [Transfusion and hemostasis: unavoidable commitment for modern anesthesiology.] Rev Esp Anestesiol Reanim 2003; 50: 495-7. [In Spanish.]
12. Colomina MJ, Basora Macaya M, Bisbe Vives E. [Implementation of blood sparing programs in Spain: results of a survey of departments of anesthesiology and resuscitation]. Rev Esp Anestesiol Reanim 2015; 62 (Suppl 1): 3-18. [In Spanish.]
13. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
14. Jans O, Jorgensen C, Kehlet H, Johansson PI;Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014; 54: 717-26.
15. Leal-Noval SR, Muñoz M, Asuero M, et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus 2013; 11: 585-610.
16. Anthes E. Evidence-based medicine: save blood, save lives. Nature 2015; 520: 24-6.
17. Saleh E, McClelland DB, Hay A, et al. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007; 99: 801-8.
18. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
19. Salido JA, Marin LA, Gomez LA, et al. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002; 84-A: 216-20.
20. Shander A, Knight K, Thurer R, et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116 (Suppl 7A): 58S-69S.
21. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482-95.
22. Bisbe E, Castillo J, Sáez M, et al. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective orthopedic surgery. Transfus Alternatives Transfus Med 2009; 10: 166-73.
23. Basora M, Tio M, Martin N, et al. Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty? Vo x Sang 2014; 107: 148-52.
24. Lasocki S, Krauspe R, von Heymann C, et al. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol 2015; 32: 160-7.
25. Va n Iperen CE, Kraaijenhagen RJ, Biesma DH, et al. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41-5.
26. Enko D, Wallner F, von-Goedecke A, et al. The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia 2013; 2013: 641876.
27. Basora M, Deulofeu R, Salazar F, et al. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement. Clin Lab Haematol 2006; 28: 370-5.
28. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8.
29. Bisbe E, Castillo J, Nomen N, et al. [Preoperative erythropoietin as blood conservation technique for elderly patients in elective orthopedic surgery]. Med Clin (Barc) 2004; 123: 413-5. [In Spanish.]
30. Bisbe E, Basora M. [Algorithm for treating preoperative anemia]. Rev Esp Anestesiol Reanim 2015; 62 (Suppl 1): 27-34. [In Spanish.]
31. Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus 2016; 14: 23-65.
32. Basora Macaya M, Bisbe Vives E. [The first pillar of patient blood management. Types of anemia and diagnostic parameters]. Rev Esp Anestesiol Reanim 2015; 62 (Suppl 1): 19-26. [In Spanish.]
33. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
34. Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990; 88: 205-9.
35. Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161: 639-48.
36. Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. Biomed Res Int 2013; 2013: 603786.
37. Basora M, Colomina MJ, Tio M, et al. Optimizing preoperative haemoglobin with intravenous iron. Br J Anaesth 2013; 110: 488-90.
38. Bisbe E. Role of iron replacement in the management of preoperative anemia. Transfus Alternatives Transfus Med 2012; 12: 150-6.
39. Muñoz M, Garcia-Erce JA, Cuenca J, et al; AWGE (Spanish Anaemia Working Group). On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus 2012; 10: 8-22.
40. Bisbe E, Garcia-Erce JA, Diez-Lobo AI, Muñoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107: 477-8.
41. Muñoz M, Garcia-Erce JA, Diez-Lobo AI, et al. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. Med Clin (Barc) 2009; 132: 303-6. [In Spanish.]
42. Weber EW, Slappendel R, Hemon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005; 22: 249-57.
43. Theusinger OM, Kind SL, Seifert B, et al. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus 2014; 12: 195-203.
44. Muñoz M, Gomez-Ramirez S, Garcia-Erce JA. Implementing patient blood management in major orthopaedic procedures: orthodoxy or pragmatism? Blood Transfus 2014; 12: 146-9.
45. So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip-and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology 2014; 120: 852-60.
46. Carless PA, Henry DA, Carson JL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2010; 10: CD002042.
47. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
48. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
49. Carson JL, Terrin ML, Jay M. Anemia and postoperative rehabilitation. Can J Anaesth 2003; 50 (6 Suppl): S60-4.
50. Bisbe E, Molto L, Arroyo R, et al. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014; 113: 402-9.
51. Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. J Bone Joint Surg Am 2010; 92: 265-9.
52. Muñoz M, Naveira E, Seara J, Cordero J. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 2012; 108: 532-4.
53. Muñoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54: 289-99.
54. Serrano-Trenas JA, Ugalde PF, Cabello LM, et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011; 51: 97-104.
55. Kotze A, Harris A, Baker C, et al. British Committee for Standards in Haematology guidelines on the identification and management of pre-operative anaemia. Br J Haematol 2015; 171: 322-31.
56. Berniere J, Dehullu JP, Gall O, Murat I. [Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents]. Rev Chir Orthop Reparatrice Appar Mot 1998; 84: 319-22. [In Spanish.]
57. Garcia-Erce JA, Cuenca J, Martinez F, et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006; 16: 335-41.
58. Karkouti K, McCluskey SA, Ghannam M, et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006; 53: 11-9.
59. Hofmann A, Ozawa S, Farrugia A, et al. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 2013; 27: 59-68.
60. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
61. Bisbe Vives E. [Treatment of anemia in patient blood management from an economic perspective]. Rev Esp Anestesiol Reanim 2015; 62 (Suppl 1): 80-5. [In Spanish.]
62. Morton J, Anastassopoulos KP, Patel ST, et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual 2010; 25: 289-96.
63. Calvet X, Gene E, AngelRuiz M, et al. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technol Health Care 2016; 24: 111-20.
64. Muñoz M, Gomez-Ramirez S, Martin-Montanez E, et al. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfus 2014; 12: 40-9.
65. Freedman J. The ONTraC Ontario program in blood conservation. Transfus Apher Sci 2014; 50: 32-6.